Protalix BioTherapeutics

PLX

Börsenwert 208 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Federated Hermes Pittsburgh, Pennsylvania	17,2 Mio. $	-386.690 $	-18.000	-2 %
2	2 Baillie Gifford & Co Edinburgh, United Kingdom	12 Mio. $	–	–	–
3	CCM 3 Consonance Capital Management New York	9,34 Mio. $	+107.414 $	+5.000	+1 %
4	4 Camber Capital Management Boston, Massachusetts	3,68 Mio. $	–	–	–
5	5 BlackRock Advisors Wilmington, Delaware	3,03 Mio. $	-121.915 $	-5.675	-3 %
6	DCM 6 DAFNA Capital Management Los Angeles, California	2,55 Mio. $	+205.053 $	+9.545	+7 %
7	7 Menora Mivtachim Holdings Ramat Gan, Israel	2,21 Mio. $	–	–	–
8	8 RTW Investments New York	1,55 Mio. $	+1,81 Mio. $	+84.385	Neu
9	9 Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel	1,29 Mio. $	–	–	–
10	10 California Public Employees Retirement System Sacramento, California	1,23 Mio. $	+1,1 Mio. $	+51.190	+674 %
11	11 BlackRock Group London, United Kingdom	1,01 Mio. $	–	–	–
12	12 BlackRock New York	625.000 $	–	–	–
13	13 State of Wisconsin Investment Board Madison, Wisconsin	477.000 $	-321.812 $	-14.980	-37 %
14	14 Bridgeway Capital Management Houston, Texas	458.000 $	+104.858 $	+4.881	+24 %
15	GPP 15 Great Point Partners Greenwich, Connecticut	392.000 $	+458.056 $	+21.322	Neu
16	16 D.E. Shaw & Co New York	332.000 $	+209.994 $	+9.775	+118 %
17	17 Morgan Stanley New York	298.000 $	+52.031 $	+2.422	+18 %
18	18 BNP Paribas Financial Markets Paris, France	223.663 $	-187.201 $	-8.714	-42 %
19	OAM 19 Oxford Asset Management Oxford, United Kingdom	162.000 $	+184.924 $	+8.608	Neu
20	20 Oppenheimer & Co New York	147.000 $	-36.521 $	-1.700	-18 %
21	SIM 21 Spark Investment Management New York	147.000 $	-29.002 $	-1.350	-14 %
22	PVH 22 Psagot Value Holdings Tel Aviv, Israel	132.000 $	–	–	–
23	TC 23 TFS Capital West Chester, Pennsylvania	111.000 $	-453.480 $	-21.109	-78 %
24	24 Susquehanna International Group Bala Cynwyd, Pennsylvania	107.000 $	-85.695 $	-3.989	-41 %
25	25 Jane Street New York	91.000 $	+32.976 $	+1.535	+45 %

Protalix BioTherapeutics PLX Börsenwert 208 Mio. $

Protalix BioTherapeutics

PLX

Börsenwert 208 Mio. $